US | EU5 | |
---|---|---|
Country, n (%) | ||
US | 289 (100.0) | – |
EU5 | 1037 (100.0) | |
France | – | 347 (33.5) |
Germany | – | 379 (36.5) |
Italy | – | 55 (5.3) |
Spain | – | 171 (16.5) |
UK | – | 85 (8.2) |
Age, years | ||
Mean (SD) | 42.9 (14.9) | 39.2 (13.8) |
Sex, n (%) | ||
Male | 148 (51.2) | 577 (55.6) |
Female | 141 (48.8) | 460 (44.4) |
Duration since diagnosis, years | ||
Mean (SD) | 6.4 (7.0) | 5.3 (5.9) |
Body mass index | ||
Mean (SD) | 25.7 (4.7) | 24.0 (4.2) |
Smoking status, n (%) | ||
Current smoker | 23 (8.3) | 151 (16.0) |
Ex-smoker | 88 (31.7) | 295 (31.2) |
Never smoked | 167 (60.1) | 499 (52.8) |
Comorbidities, n (%)a | ||
Hypertension | 73 (25.3) | 111 (10.7) |
Anxiety | 54 (18.7) | 110 (10.6) |
Hyperlipidemia | 46 (15.9) | 69 (6.7) |
Depression | 33 (11.4) | 55 (5.3) |
Diabetes (with or without chronic complications) | 21 (7.3) | 30 (2.9) |
Osteoarthritis | 15 (5.2) | 25 (2.4) |
Anemia | 10 (3.5) | 61 (5.9) |
Osteoporosis | 9 (3.1) | 24 (2.3) |
Charlson Comorbidity Index score | ||
Mean (SD) | 0.2 (0.6) | 0.2 (0.6) |